SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
SanBio Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
January 31, 2020 | -8.20K% |
October 31, 2019 | |
July 31, 2019 | -550.7% |
April 30, 2019 | -388.7% |
January 31, 2019 | -793.8% |
October 31, 2018 | -331.2% |
July 31, 2018 | -79.42% |
April 30, 2018 | -528.6% |
January 31, 2018 | -655.4% |
October 31, 2017 | -727.5% |
July 31, 2017 | -935.1% |
Date | Value |
---|---|
April 30, 2017 | -885.9% |
January 31, 2017 | -74.93% |
October 31, 2016 | -741.7% |
July 31, 2016 | -1.48K% |
April 30, 2016 | -44.34% |
January 31, 2016 | -688.7% |
October 31, 2015 | -4.48% |
July 31, 2015 | -261.5% |
April 30, 2015 | -38.31% |
January 31, 2015 | -162.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-8.20K%
Minimum
Jan 2020
-8.20K%
Maximum
Jan 2020
-8.20K%
Average
-8.20K%
Median
Jan 2020
Profit Margin (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 7.83% |
Nxera Pharma Co Ltd | 12.95% |
PeptiDream Inc | 58.82% |
Healios KK | -107.2% |
AnGes Inc | -2.95K% |